mAbs

Keyphrases

Publications

volume 15, number 1, 2023

Hristo L Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15 (1) (2023)
Saw Yen Ow, Eugene A Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, Michael J Wilson, Andrew D Nash, Matthias Pelzing
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. mAbs 15 (1) (2023)
Saw Yen Ow, Eugene A Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, Michael J Wilson, Andrew D Nash, Matthias Pelzing
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Janik Kokot, Franz Waibl, Anna-Lena M Fischer, Patrick K Quoika, Charlotte M Deane, Klaus Roman Liedl
Challenges in antibody structure prediction. mAbs 15 (1) (2023)
Jonathan Schmitt, Abbas Razvi, Christoph Grapentin
Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks. mAbs 15 (1) (2023)
Tsega L Solomon, Frank Delaglio, John P Giddens, John P Marino, Yihua Bruce Yu, Marc B Taraban, Robert G Brinson
Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb. mAbs 15 (1) (2023)
Christina Claus, Claudia Ferrara-Koller, Christian Klein
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. mAbs 15 (1) (2023)
Sarah-Jane Kellmann, Christian Hentrich, Mateusz Putyrski, Hanh Hanuschka, Manuel Cavada, Achim Knappik, Francisco Ylera
SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Tiphanie Pruvost, Magali Mathieu, Steven Dubois, Bernard Maillère, Emmanuelle Vigne, Hervé Nozach
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Janik Kokot, Franz Waibl, Anna-Lena M Fischer, Patrick K Quoika, Charlotte M Deane, Klaus Roman Liedl
Challenges in antibody structure prediction. mAbs 15 (1) (2023)
Tiphanie Pruvost, Magali Mathieu, Steven Dubois, Bernard Maillère, Emmanuelle Vigne, Hervé Nozach
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold. mAbs 15 (1) (2023)
Emma Davé, Oliver Durrant, Neha Dhami, Joanne Compson, Janice Broadbridge, Sophie Archer, Asher Maroof, Kevin Whale, Karelle Menochet, Pierre Bonnaillie, Emily Barry, Gavin Wild, Claude Peerboom, Pallavi Bhatta, Mark Ellis, Matthew Hinchliffe, David P Humphreys, Sam P Heywood
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life. mAbs 15 (1) (2023)
Ameya Harmalkar, Roshan Rao, Yuxuan Richard Xie, Jonas Honer, Wibke Deisting, Jonas Anlahr, Anja Hoenig, Julia Czwikla, Eva Sienz-Widmann, Doris Rau, Austin J Rice, Timothy P Riley, Danqing Li, Hannah B Catterall, Christine E Tinberg, Jeffrey J Gray, Kathy Y Wei
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features. mAbs 15 (1) (2023)
Baoshan Zhang, Jason Gorman, Young D Kwon, Amarendra Pegu, Cara W Chao, Tracy Liu, Mangaiarkarasi Asokan, Michael F Bender, Tatsiana Bylund, Leland Damron, Deepika Gollapudi, Paula Lei, Yile Li, Cuiping Liu, Mark K Louder, Krisha McKee, Adam S Olia, Reda Rawi, Arne Schön, Shuishu Wang, Eun Sung Yang, Yongping Yang, Kevin Carlton, Nicole A Doria-Rose, Lawrence Shapiro, Michael S Seaman, John R Mascola, Peter D Kwong
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Kathryn Ball, Simon J Dovedi, Pavan Vajjah, Alex Phipps
Strategies for clinical dose optimization of T cell-engaging therapies in oncology. mAbs 15 (1) (2023)
Hristo L Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15 (1) (2023)
Sarah-Jane Kellmann, Christian Hentrich, Mateusz Putyrski, Hanh Hanuschka, Manuel Cavada, Achim Knappik, Francisco Ylera
SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology. mAbs 15 (1) (2023)
Hristo L Svilenov, Paolo Arosio, Tim Menzen, Peter Tessier, Pietro Sormanni
Approaches to expand the conventional toolbox for discovery and selection of antibodies with drug-like physicochemical properties. mAbs 15 (1) (2023)
Kathryn Ball, Simon J Dovedi, Pavan Vajjah, Alex Phipps
Strategies for clinical dose optimization of T cell-engaging therapies in oncology. mAbs 15 (1) (2023)
Sarah-Jane Kellmann, Christian Hentrich, Mateusz Putyrski, Hanh Hanuschka, Manuel Cavada, Achim Knappik, Francisco Ylera
SpyDisplay: A versatile phage display selection system using SpyTag/SpyCatcher technology. mAbs 15 (1) (2023)
Tiphanie Pruvost, Magali Mathieu, Steven Dubois, Bernard Maillère, Emmanuelle Vigne, Hervé Nozach
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold. mAbs 15 (1) (2023)
Dario A T Cramer, Vojtech Franc, Anna-Katharina Heidenreich, Michaela Hook, Mahdi Adibzadeh, Dietmar Reusch, Albert J R Heck, Markus Haberger
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody. mAbs 15 (1) (2023)
Tiphanie Pruvost, Magali Mathieu, Steven Dubois, Bernard Maillère, Emmanuelle Vigne, Hervé Nozach
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold. mAbs 15 (1) (2023)
Emma Davé, Oliver Durrant, Neha Dhami, Joanne Compson, Janice Broadbridge, Sophie Archer, Asher Maroof, Kevin Whale, Karelle Menochet, Pierre Bonnaillie, Emily Barry, Gavin Wild, Claude Peerboom, Pallavi Bhatta, Mark Ellis, Matthew Hinchliffe, David P Humphreys, Sam P Heywood
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Janik Kokot, Franz Waibl, Anna-Lena M Fischer, Patrick K Quoika, Charlotte M Deane, Klaus Roman Liedl
Challenges in antibody structure prediction. mAbs 15 (1) (2023)
Emma Davé, Oliver Durrant, Neha Dhami, Joanne Compson, Janice Broadbridge, Sophie Archer, Asher Maroof, Kevin Whale, Karelle Menochet, Pierre Bonnaillie, Emily Barry, Gavin Wild, Claude Peerboom, Pallavi Bhatta, Mark Ellis, Matthew Hinchliffe, David P Humphreys, Sam P Heywood
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Janik Kokot, Franz Waibl, Anna-Lena M Fischer, Patrick K Quoika, Charlotte M Deane, Klaus Roman Liedl
Challenges in antibody structure prediction. mAbs 15 (1) (2023)
Emma Davé, Oliver Durrant, Neha Dhami, Joanne Compson, Janice Broadbridge, Sophie Archer, Asher Maroof, Kevin Whale, Karelle Menochet, Pierre Bonnaillie, Emily Barry, Gavin Wild, Claude Peerboom, Pallavi Bhatta, Mark Ellis, Matthew Hinchliffe, David P Humphreys, Sam P Heywood
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life. mAbs 15 (1) (2023)
Jonathan Schmitt, Abbas Razvi, Christoph Grapentin
Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks. mAbs 15 (1) (2023)
Christina Claus, Claudia Ferrara-Koller, Christian Klein
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. mAbs 15 (1) (2023)
Tomoyuki Ito, Thuy Duong Nguyen, Yutaka Saito, Yoichi Kurumida, Hikaru Nakazawa, Sakiya Kawada, Hafumi Nishi, Koji Tsuda, Tomoshi Kameda, Mitsuo Umetsu
Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning. mAbs 15 (1) (2023)
Christina Claus, Claudia Ferrara-Koller, Christian Klein
The emerging landscape of novel 4-1BB (CD137) agonistic drugs for cancer immunotherapy. mAbs 15 (1) (2023)
André Luiz Lourenço, Shih-Wei Chuo, Markus F Bohn, Byron Hann, Shireen Khan, Neha Yevalekar, Nitin Patel, Teddy Yang, Lina Xu, Dandan Lv, Robert Drakas, Sarah Lively, Charles S Craik
High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions. mAbs 15 (1) (2023)
Tiphanie Pruvost, Magali Mathieu, Steven Dubois, Bernard Maillère, Emmanuelle Vigne, Hervé Nozach
Deciphering cross-species reactivity of LAMP-1 antibodies using deep mutational epitope mapping and AlphaFold. mAbs 15 (1) (2023)
Baoshan Zhang, Jason Gorman, Young D Kwon, Amarendra Pegu, Cara W Chao, Tracy Liu, Mangaiarkarasi Asokan, Michael F Bender, Tatsiana Bylund, Leland Damron, Deepika Gollapudi, Paula Lei, Yile Li, Cuiping Liu, Mark K Louder, Krisha McKee, Adam S Olia, Reda Rawi, Arne Schön, Shuishu Wang, Eun Sung Yang, Yongping Yang, Kevin Carlton, Nicole A Doria-Rose, Lawrence Shapiro, Michael S Seaman, John R Mascola, Peter D Kwong
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. mAbs 15 (1) (2023)
Dario A T Cramer, Vojtech Franc, Anna-Katharina Heidenreich, Michaela Hook, Mahdi Adibzadeh, Dietmar Reusch, Albert J R Heck, Markus Haberger
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody. mAbs 15 (1) (2023)
Saw Yen Ow, Eugene A Kapp, Vesna Tomasetig, Anton Zalewski, Jason Simmonds, Con Panousis, Michael J Wilson, Andrew D Nash, Matthias Pelzing
HDX-MS study on garadacimab binding to activated FXII reveals potential binding interfaces through differential solvent exposure. mAbs 15 (1) (2023)
Baoshan Zhang, Jason Gorman, Young D Kwon, Amarendra Pegu, Cara W Chao, Tracy Liu, Mangaiarkarasi Asokan, Michael F Bender, Tatsiana Bylund, Leland Damron, Deepika Gollapudi, Paula Lei, Yile Li, Cuiping Liu, Mark K Louder, Krisha McKee, Adam S Olia, Reda Rawi, Arne Schön, Shuishu Wang, Eun Sung Yang, Yongping Yang, Kevin Carlton, Nicole A Doria-Rose, Lawrence Shapiro, Michael S Seaman, John R Mascola, Peter D Kwong
Bispecific antibody CAP256.J3LS targets V2-apex and CD4-binding sites with high breadth and potency. mAbs 15 (1) (2023)
Jonathan Schmitt, Abbas Razvi, Christoph Grapentin
Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks. mAbs 15 (1) (2023)
Kathryn Ball, Simon J Dovedi, Pavan Vajjah, Alex Phipps
Strategies for clinical dose optimization of T cell-engaging therapies in oncology. mAbs 15 (1) (2023)
Tsega L Solomon, Frank Delaglio, John P Giddens, John P Marino, Yihua Bruce Yu, Marc B Taraban, Robert G Brinson
Correlated analytical and functional evaluation of higher order structure perturbations from oxidation of NISTmAb. mAbs 15 (1) (2023)
Tomoyuki Ito, Thuy Duong Nguyen, Yutaka Saito, Yoichi Kurumida, Hikaru Nakazawa, Sakiya Kawada, Hafumi Nishi, Koji Tsuda, Tomoshi Kameda, Mitsuo Umetsu
Selection of target-binding proteins from the information of weakly enriched phage display libraries by deep sequencing and machine learning. mAbs 15 (1) (2023)
Lennart Kühl, Annelie K Schäfer, Sebastian Kraft, Nadine Beha, Roland E Kontermann, Oliver Seifert
eIg-based bispecific T-cell engagers targeting EGFR: Format matters. mAbs 15 (1) (2023)
Monica L Fernández-Quintero, Anne Ljungars, Franz Waibl, Victor Greiff, Jan Terje Andersen, Torleif Tollefsrud Gjølberg, Timothy Patrick Jenkins, Bjørn Gunnar Voldborg, Lise Marie Grav, Sandeep Kumar, Guy Georges, Hubert Kettenberger, Klaus Roman Liedl, Peter M Tessier, John McCafferty, Andreas Hougaard Laustsen
Assessing developability early in the discovery process for novel biologics. mAbs 15 (1) (2023)
Dario A T Cramer, Vojtech Franc, Anna-Katharina Heidenreich, Michaela Hook, Mahdi Adibzadeh, Dietmar Reusch, Albert J R Heck, Markus Haberger
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody. mAbs 15 (1) (2023)
Dario A T Cramer, Vojtech Franc, Anna-Katharina Heidenreich, Michaela Hook, Mahdi Adibzadeh, Dietmar Reusch, Albert J R Heck, Markus Haberger
Characterization of high-molecular weight by-products in the production of a trivalent bispecific 2+1 heterodimeric antibody. mAbs 15 (1) (2023)
Emma Davé, Oliver Durrant, Neha Dhami, Joanne Compson, Janice Broadbridge, Sophie Archer, Asher Maroof, Kevin Whale, Karelle Menochet, Pierre Bonnaillie, Emily Barry, Gavin Wild, Claude Peerboom, Pallavi Bhatta, Mark Ellis, Matthew Hinchliffe, David P Humphreys, Sam P Heywood
TRYBE®: an Fc-free antibody format with three monovalent targeting arms engineered for long in vivo half-life. mAbs 15 (1) (2023)
Ameya Harmalkar, Roshan Rao, Yuxuan Richard Xie, Jonas Honer, Wibke Deisting, Jonas Anlahr, Anja Hoenig, Julia Czwikla, Eva Sienz-Widmann, Doris Rau, Austin J Rice, Timothy P Riley, Danqing Li, Hannah B Catterall, Christine E Tinberg, Jeffrey J Gray, Kathy Y Wei
Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features. mAbs 15 (1) (2023)